Blier P - Search Results

1

A double-blind, placebo-controlled trial of olanzapine addition in fluoxetine-refractory obsessive-compulsive disorder.

Shapira NA, Ward HE, Mandoki M, Murphy TK, Yang MC, Blier P, Goodman WK. Shapira NA, et al. Among authors: blier p. Biol Psychiatry. 2004 Mar 1;55(5):553-5. doi: 10.1016/j.biopsych.2003.11.010. Biol Psychiatry. 2004. PMID: 15023585 Clinical Trial.

2

Combination of antidepressant medications from treatment initiation for major depressive disorder: a double-blind randomized study.

Blier P, Ward HE, Tremblay P, Laberge L, Hébert C, Bergeron R. Blier P, et al. Am J Psychiatry. 2010 Mar;167(3):281-8. doi: 10.1176/appi.ajp.2009.09020186. Epub 2009 Dec 15. Am J Psychiatry. 2010. PMID: 20008946 Clinical Trial.

3

Toward optimal treatments for major depression.

Blier P, Ward H. Blier P, et al. CNS Spectr. 2002 Feb;7(2):148-50, 153-4. doi: 10.1017/s1092852900017466. CNS Spectr. 2002. PMID: 15220857

4

Possible serotonergic mechanisms underlying the antidepressant and anti-obsessive-compulsive disorder responses.

Blier P, de Montigny C. Blier P, et al. Biol Psychiatry. 1998 Sep 1;44(5):313-23. doi: 10.1016/s0006-3223(98)00114-0. Biol Psychiatry. 1998. PMID: 9755353 Review.

5

Effect of long-term administration of antidepressant treatments on serotonin release in brain regions involved in obsessive-compulsive disorder.

Bergqvist PB, Bouchard C, Blier P. Bergqvist PB, et al. Among authors: blier p. Biol Psychiatry. 1999 Jan 15;45(2):164-74. doi: 10.1016/s0006-3223(98)00154-1. Biol Psychiatry. 1999. PMID: 9951563

6

Is there a role for 5-HT1A agonists in the treatment of depression?

Blier P, Ward NM. Blier P, et al. Biol Psychiatry. 2003 Feb 1;53(3):193-203. doi: 10.1016/s0006-3223(02)01643-8. Biol Psychiatry. 2003. PMID: 12559651 Review.

7

Mechanisms of action of current and potential pharmacotherapies of obsessive-compulsive disorder.

El Mansari M, Blier P. El Mansari M, et al. Among authors: blier p. Prog Neuropsychopharmacol Biol Psychiatry. 2006 May;30(3):362-73. doi: 10.1016/j.pnpbp.2005.11.005. Epub 2006 Jan 20. Prog Neuropsychopharmacol Biol Psychiatry. 2006. PMID: 16427729 Review.

8

Pharmacotherapies in the management of obsessive-compulsive disorder.

Blier P, Habib R, Flament MF. Blier P, et al. Can J Psychiatry. 2006 Jun;51(7):417-30. doi: 10.1177/070674370605100703. Can J Psychiatry. 2006. PMID: 16838823 Review.

9

Single, Repeated, and Maintenance Ketamine Infusions for Treatment-Resistant Depression: A Randomized Controlled Trial.

Phillips JL, Norris S, Talbot J, Birmingham M, Hatchard T, Ortiz A, Owoeye O, Batten LA, Blier P. Phillips JL, et al. Among authors: blier p. Am J Psychiatry. 2019 May 1;176(5):401-409. doi: 10.1176/appi.ajp.2018.18070834. Epub 2019 Mar 29. Am J Psychiatry. 2019. PMID: 30922101 Clinical Trial.

10

Brain regional α-[11C]methyl-L-tryptophan trapping in medication-free patients with obsessive-compulsive disorder.

Berney A, Leyton M, Gravel P, Sibon I, Sookman D, Rosa Neto P, Diksic M, Nakai A, Pinard G, Todorov C, Okazawa H, Blier P, Nordahl TE, Benkelfat C. Berney A, et al. Among authors: blier p. Arch Gen Psychiatry. 2011 Jul;68(7):732-41. doi: 10.1001/archgenpsychiatry.2011.16. Epub 2011 Mar 7. Arch Gen Psychiatry. 2011. PMID: 21383250 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

515 results

Search Page

Filters